Consultation deadline 14 September 2020

A new draft guideline, Chronic pain in over 16s: assessment and management, published by the National Institute of Health and Care Excellence (NICE) is open for consultation until 14 September 2020.

The consultation recommends that people over 16 should not be offered medication to manage chronic primary pain, including opioids, non-steroidal anti-inflammatory drugs, benzodiazepines, local anaesthetic/corticosteroid combinations, paracetamol, ketamine and corticosteroids.

The draft guidance recommends the non-pharmacological management of chronic primary pain, including supervised exercise programmes and psychological therapies.

Several ARMA members are planning to respond to the consultation.

Comments are closed.